Xcopri 50 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F47JE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,478
Award facts
- Contract value 100% obligated
- $3,477.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $3,477.78 to AmerisourceBergen Drug Corp for the supply of Xcopri 50 mg tablets (30-count packaging) on January 14, 2026. This non-set-aside competitive award will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of January 15, 2026. The delivery order is executed under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999.99 billion single-award vehicle running through December 31, 2031, which provides comprehensive pharmaceutical and medical supply support to military healthcare systems globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through DLA's Medical Supply Chain. As a subsidiary of Cencora, Inc., the company maintains extensive capabilities to fulfill diverse pharmaceutical requirements across multiple therapeutic domains, demonstrated through its consistent delivery of brand-name and generic medications, vaccines, and specialized medical supplies to federal agencies on a competitive basis. This specific delivery order for Xcopri, an anti-seizure medication, represents a routine task order execution under the established pharmaceutical prime vendor framework supporting Defense Health Agency operations and broader military medical readiness.
Quick answers
Who was awarded contract SPE2DR26F47JE?
SPE2DR26F47JE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26F47JE worth?
The government has obligated $3,478 on SPE2DR26F47JE.
Is contract SPE2DR26F47JE an order under another contract?
Yes. SPE2DR26F47JE is a delivery order under SPE2DR25D2101, an indefinite delivery contract.
Was contract SPE2DR26F47JE competed?
The extent of competition for SPE2DR26F47JE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award